NOX enzymes as novel targets for drug development
Open accessThe DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Abstract
The members of the NOX/DUOX family of NADPH oxidases mediate such physiologic functions as host defense, cell signaling, and thyroid hormone biosynthesis through the generation of reactive oxygen species (ROS), including superoxide anion and hydrogen peroxide. Moreover, ROS are involved in a broad range of fundamental biochemical and cellular processes, and data accumulated in recent years indicate that the NOX enzymes comprise one of the most important biological sources of ROS. Given the high biochemical reactivity of ROS, it is not surprising that they have been implicated in a wide variety of pathologies and diseases. Prominent among the settings that feature ROS-mediated tissue injury are disorders associated with inflammation, aging, and progressive degenerative changes in cells and organ systems, and it appears that essentially no organ system is exempt. Among the disorders currently believed to be mediated at least in part by NOX-derived ROS are hypertension, aortic aneurysm, myocardial infarction (and other ischemia-reperfusion disorders), pulmonary fibrosis and hypertension, amyotropic lateral sclerosis, Alzheimer's disease, Parkinson's disease, ischemic stroke, diabetic nephropathy, and renal cell carcinoma. Several small-molecule and peptide inhibitors of the NOX enzymes have been useful in experimental studies, but issues of specificity, potency, and toxicity militate against any of the existing published compounds as candidates for drug development. Given the br…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes Nox enzymes but also, for example, complex I of the ETC [63,250,251], iNOS [400,401] and XO [394,399] as well as calcium transporters [402].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [250]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Self-citationIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,631
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
Self-citationMitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Cited by
Reperfusion injury and reactive oxygen species: The evolution of a concept
Granger, D. N., & Kvietys, P. R. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.020 · Cited by 1,484
“Apocynin exerts its inhibitory effect on Nox by interfering with membrane translocation of p47 and p67, while DPI, a flavoprotein inhibitor, alters the electron transport capacity of the enzyme [200,201,275, 276].”
BackgroundTNF and ROS crosstalk in inflammation
Blaser, H., Dostert, C., Mak, T. W., & Brenner, D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.002 · Cited by 1,008
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Le Belle, J. E., Orozco, N. M., Paucar, A. A., Saxe, J. P., Mottahedeh, J., Pyle, A. D., Wu, H., & Kornblum, H. I. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.028 · Cited by 789
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
“This includes Nox enzymes but also, for example, complex I of the ETC [63,250,251], iNOS [400,401] and XO [394,399] as well as calcium transporters [402].”
BackgroundNOX Enzymes in the Central Nervous System: From Signaling to Disease
Sorce, S., & Krause, K.-H. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2578 · Cited by 471
Self-citationROS production in phagocytes: Why, when, and where?
Dupré-Crochet, S., Erard, M., & Nüβe, O. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012544 · Cited by 467
“ing [44, 45].”
Reactive oxygen species: Destroyers or messengers?
Bartosz, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.009 · Cited by 379
Nox4: A Hydrogen Peroxide-Generating Oxygen Sensor
Nisimoto, Y., Diebold, B. A., Cosentino-Gomes, D., & Lambeth, J. D. (2014) · Biochemistry · doi:10.1021/bi500331y · Cited by 359
Self-citationTGF-β signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities
Samarakoon, R., Overstreet, J. M., & Higgins, P. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2012.10.003 · Cited by 332
The role of myofibroblasts in wound healing
Hinz, B. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.09.003 · Cited by 328
Modulation of endogenous antioxidant system by wine polyphenols in human disease
Rodrigo, R., Miranda, A., & Vergara, L. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.11.034 · Cited by 306
“Nevertheless, it has been reported that reperfusion results in a sustained generation of ROS derived from NADPH oxidase (isoforms NOX1-4), whose isoforms are being differentially expressed across the diverse tissues [16].”
BackgroundErgothioneine – a diet‐derived antioxidant with therapeutic potential
Halliwell, B., Cheah, I. K., & Tang, R. M. Y. (2018) · FEBS Letters · doi:10.1002/1873-3468.13123 · Cited by 305
Martin, S. F., Esser, P. R., Weber, F. C., Jakob, T., Freudenberg, M. A., Schmidt, M., & Goebeler, M. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02652.x · Cited by 290
Kim, K.-H., Chen, C.-C., Monzon, R. I., & Lau, L. F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00049-13 · Cited by 261
Strategies for treating idiopathic pulmonary fibrosis
du Bois, R. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2958 · Cited by 251
“Unfortunately, toxicity and other issues have precluded the progression of NOX-targeting enzyme therapies through drug developmen”
BackgroundThe blood–brain barrier endothelium: a target for pro-inflammatory cytokines
Rochfort, K. D., & Cummins, P. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20140319 · Cited by 245
Laleu, B., Gaggini, F., Orchard, M., Fioraso-Cartier, L., Cagnon, L., Houngninou-Molango, S., Gradia, A., Duboux, G., Merlot, C., Heitz, F., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100773e · Cited by 243
Small-Molecule NOX Inhibitors: ROS-Generating NADPH Oxidases as Therapeutic Targets
Jaquet, V., Scapozza, L., Clark, R. A., Krause, K.-H., & Lambeth, J. D. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2585 · Cited by 243
“The elevated ROS production has been linked to the pathobiology of many of these conditions (59).”
Self-citationThe protective role of ROS in autoimmune disease
Hultqvist, M., Olsson, L. M., Gelderman, K. A., & Holmdahl, R. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.004 · Cited by 224
Kalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., Bennett, B., & Zielonka, J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.12.012 · Cited by 221
“, Nox2 and Nox4) have been proposed as potential therapeutic targets in the treatment of cancer and other diseases [42].”
Ebbesen, P., Pettersen, E. O., Gorr, T. A., Jobst, G., Williams, K., Kieninger, J., Wenger, R. H., Pastorekova, S., Dubois, L., Lambin, P., et al. (2009) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360902784425 · Cited by 218
Targeting the Redox Balance in Inflammatory Skin Conditions
Wagener, F., Carels, C., & Lundvig, D. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059126 · Cited by 217
“Indeed, the central role of Nox in a multitude of diseases suggests it to be a putative therapeutic target, and several Nox-targeting inhibitors have been developed [263,264] with the main focus on the macrophage-specific Nox2 due to its involvement in several inflammatory conditions [173].”
BackgroundNADPH Oxidases: A Perspective on Reactive Oxygen Species Production in Tumor Biology
Meitzler, J. L., Antony, S., Wu, Y., Juhasz, A., Liu, H., Jiang, G., Lu, J., Roy, K., & Doroshow, J. H. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5603 · Cited by 201
“The structural homologies among the NOX family have hindered both targeted therapeutic intervention and antibody development (3, 32, 72).”
BackgroundNOX2 Complex–Derived ROS as Immune Regulators
Sareila, O., Kelkka, T., Pizzolla, A., Hultqvist, M., & Holmdahl, R. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3635 · Cited by 200
“The lack of inhibitor specificity has made it difficult to investigate the source of ROS or to assess the role of specific NOX complexes (44, 52).”
Gianni, D., Taulet, N., Zhang, H., DerMardirossian, C., Kister, J., Martinez, L., Roush, W. R., Brown, S. J., Bokoch, G. M., & Rosen, H. (2010) · ACS Chemical Biology · doi:10.1021/cb100219n · Cited by 192
Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury
Dohi, K., Ohtaki, H., Nakamachi, T., Yofu, S., Satoh, K., Miyamoto, K., Song, D., Tsunawaki, S., Shioda, S., & Aruga, T. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-41 · Cited by 188
“Many studies investigating ischemic injury suggest that inhibition of NADPH oxidase or gp91 phox is an important therapeutic target for neuroprotection [39,40].”
BackgroundWind, S., Beuerlein, K., Armitage, M. E., Taye, A., Kumar, A. H. S., Janowitz, D., Neff, C., Shah, A. M., Wingler, K., & Schmidt, H. H. H. W. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149187 · Cited by 181
NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology
Manea, A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1060-y · Cited by 166
“…cultures, and isolated tissues have demonstrated that the pharmacological inhibition of Nox complexes might be more effective in modulating ROS production, rather than the scavenging of ROS by antioxidant vitamins (Lambeth et al. 2008; Selemidis et al. 2008; Jaquet et al. 2009; Seitz et al. 2010).”
BackgroundThe Role of Oxidative Stress in Cerebral Aneurysm Formation and Rupture
Starke, R. M., Chalouhi, N., Ali, M. S., Jabbour, P. M., Tjoumakaris, S. I., Gonzalez, L. F., Rosenwasser, R. H., Koch, W. J., & Dumont, A. S. (2013) · Current Neurovascular Research · doi:10.2174/15672026113109990003 · Cited by 163
The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis.
Mirshafiey, A., & Mohsenzadegan, M. (2008) · PubMed · Cited by 191
Redox Control of the Survival of Healthy and Diseased Cells
Zhang, Y., Du, Y., Le, W., Wang, K., Kieffer, N., & Zhang, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3685 · Cited by 153
“Their inhibitory effect occurs through acceptance of an electron from the flavin to generate a radical species that then covalently modifies the flavin coenzyme itself or its active site (193).”
Nox enzymes from fungus to fly to fish and what they tell us about Nox function in mammals
Aguirre, J., & Lambeth, J. D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.027 · Cited by 158
“We suggest that many of the roles of Nox enzymes in higher organisms can be interpreted in terms of a local or systemic stress response, for example, to tissue damage, toxins and infection, and that much of the Noxdependent pathology [76–78] that is seen in higher organisms results from a persistently activated stress…”
BackgroundSelf-citationReactive oxygen and nitrogen species in normal physiological processes
Pourova, J., Kottova, M., Voprsalova, M., & Pour, M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02039.x · Cited by 146
“Several Nox inhibitors, the effects of which are being investigated, have been reported (for a review, see Lambeth et al. 2008).”
BackgroundTargeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism
Garrido-Urbani, S., Jemelin, S., Deffert, C., Carnesecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014665 · Cited by 143
“As in certain pathologies this balance becomes deregulated and much effort has been put into development of inhibitors of ROS production [59].”
BackgroundSelf-citationNox4 and diabetic nephropathy: With a friend like this, who needs enemies?
Gorin, Y., & Block, K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.014 · Cited by 134
Guichard, C., Moreau, R., Pessayre, D., Epperson, T. K., & Krause, K. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360920 · Cited by 150
Self-citationWeaver, J. R., Holman, T. R., Imai, Y., Jadhav, A., Kenyon, V., Maloney, D. J., Nadler, J. L., Rai, G., Simeonov, A., & Taylor-Fishwick, D. A. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.004 · Cited by 133
“The use of apocynin and DPI is however controversial since inhibition of other enzyme pathways have been attributed to their spectra of action (Lambeth et al., 2008).”
BackgroundRabbani, N., Chittari, M. V., Bodmer, C. W., Zehnder, D., Ceriello, A., & Thornalley, P. J. (2010) · Diabetes · doi:10.2337/db09-1455 · Cited by 122
“Enzymatic formation is catalyzed by dual oxidase-1 (22)—a member of the NADPH oxidase family of enzymes implicated in signaling in vascular disease in diabetes (23).”
BackgroundNADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action
Jaquet, V., Marcoux, J., Forest, E., Leidal, K. G., McCormick, S., Westermaier, Y., Perozzo, R., Plastre, O., Fioraso‐Cartier, L., Diebold, B., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01439.x · Cited by 119
“The role of NOX enzymes in oxidative stress-related pathologies is increasingly recognized, in particular for cardiovascular and neurodegenerative diseases, and they represent a promising pharmacological target (Lambeth et al., 2008).”
BackgroundSelf-citationAdvances in lupus genetics and epigenetics
Deng, Y., & Tsao, B. P. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000086 · Cited by 139
“ROS produced by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex are essential in defense against invading pathogens and are likely to promote cellular and tissue damage owing to their highly reactive nature [70].”
BackgroundNox as a target for diabetic complications
Gorin, Y., & Block, K. (2013) · Clinical Science · doi:10.1042/cs20130065 · Cited by 120
Smith, S. M. E., Min, J., Ganesh, T., Diebold, B., Kawahara, T., Zhu, Y., McCoy, J., Sun, A., Snyder, J. P., Fu, H., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.04.015 · Cited by 112
“The status of development of drugs/inhibitors targeting Nox enzymes has been reviewed recently (Lambeth et al., 2008; Jaquet et al., 2009).”
BackgroundSelf-citationPhysiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme
Katsuyama, M., Matsuno, K., & Yabe-Nishimura, C. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-06sr · Cited by 116
Gianni, D., Taulet, N., DerMardirossian, C., & Bokoch, G. M. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0685 · Cited by 112
“All Nox enzymes have been implicated in physiological and pathophysiological processes (Bedard and Krause, 2007; Lambeth et al., 2008).”
Ivanova, D., Zhelev, Z., Aoki, I., Bakalova, R., & Higashi, T. (2016) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2016.04.01 · Cited by 119
Novel p47 phox -Related Organizers Regulate Localized NADPH Oxidase 1 (Nox1) Activity
Gianni, D., Diaz, B., Taulet, N., Fowler, B., Courtneidge, S. A., & Bokoch, G. M. (2009) · Science Signaling · doi:10.1126/scisignal.2000370 · Cited by 109
“ROS generated through Nox also contribute to a number of diseases, including atherosclerosis, hypertension, arthritis, Alzheimer’s disease and other neurological disorders, stroke, respiratory syndromes, cancer, and inflammation (5, 6).”
BackgroundWu, Y., Yang, Y., Zhao, W., Xu, Z. P., Little, P. J., Whittaker, A. K., Zhang, R., & Ta, H. T. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00022k · Cited by 109
Wang, Q., Qian, L., Chen, S.-H., Chu, C.-H., Wilson, B., Oyarzabal, E., Ali, S., Robinson, B., Rao, D., & Hong, J.-S. (2015) · Brain · doi:10.1093/brain/awv034 · Cited by 102
Mesquita, F. S., Dyer, S. N., Heinrich, D. A., Bulun, S. E., Marsh, E. E., & Nowak, R. A. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.075887 · Cited by 109
“Drugs that can target the NADPH oxidase complex such as specific inhibitors of the NOX/DUOX family members represent potential therapeutic approaches for treatment of these chronic diseases [61].”
BackgroundFernandes, D. C., Manoel, A. H. O., Wosniak, J., & Laurindo, F. R. M. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.01.022 · Cited by 109
Ushio‐Fukai, M., Ash, D., Nagarkoti, S., de Chantemèle, E. J. B., Fulton, D. J., & Fukai, T. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8161 · Cited by 102
“These similarities have created difficulties for those designing targeted therapies (184).”
NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress
Diebold, B. A., Smith, S. M., Yang, L., & Lambeth, J. D. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5862 · Cited by 105
“, phosphorylation, transcription) for cells to regulate their ROS levels both acutely and chronically (17, 156).”
Self-citationNADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS
Cifuentes-Pagano, E., Csanyi, G., & Pagano, P. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1009-2 · Cited by 92
“Oxidative stress has clearly been implicated in a broad range of pathophysiological conditions including hypertension, diabetes, atherosclerosis, Parkinson’s disease, Alzheimer’s disease, and cancer [1–4].”
Reactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 87
Role of Nox2 in elimination of microorganisms
Rada, B., Hably, C., Meczner, A., Tímár, C. I., Lakatos, G., Enyedi, P., & Ligeti, E. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0126-3 · Cited by 104
“At present, no efficient inhibitors are available that would be specific for any Nox or cell type [ 82 ] (the widely used inhibitor DPI interacts with almost any heme protein).”
BackgroundActivin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies
Lim, R., Acharya, R. Y., Delpachitra, P., Hobson, S. R., Sobey, C. G., Drummond, G. R., & Wallace, E. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.07.021 · Cited by 91
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
“Increasing evidence demonstrates Nox as a main cellular source of ROS, playing an important role in ROS-dependent signaling cascades (20, 98).”
BackgroundActivation of Microglia Depends on Na+/H+Exchange-Mediated H+Homeostasis
Liu, Y., Kintner, D. B., Chanana, V., Algharabli, J., Chen, X., Gao, Y., Chen, J., Ferrazzano, P. A., Olson, J. K., & Sun, D. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3950-10.2010 · Cited by 94
“It not only inhibits all NOX isoforms but also other electron transporters, such as nicotinamide adenine dinucleotide coenzyme Q reductase and nitric oxide synthase (Lambeth et al., 2008).”
BackgroundWang, Q., Chu, C.-H., Qian, L., Chen, S.-H., Wilson, B., Oyarzabal, E., Jiang, L., Ali, S., Robinson, B., Kim, H.-C., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2238-14.2014 · Cited by 83
“The overproduction of NOX2generated superoxide is critically linked to the secretion of a wide spectrum of proinflammatory factors from microglia, leading to chronic neuroinflammation and dopaminergic degeneration (Lambeth et al., 2008; Sorce and Krause, 2009).”
BackgroundOxidative Stress and Skin Fibrosis
Shroff, A., Mamalis, A., & Jagdeo, J. R. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0062-y · Cited by 89
Chen, X., Liu, Y., Guo, Z., Chen, Z., Chen, Y., Li, M., Huang, C., Zhang, X., & Chen, L. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.261 · Cited by 84
“dinucleotide phosphate (NADPH) oxidase enzymes (NOX) and passively by mitochondria.(9,10) Culture of ADSCs under”
BackgroundTargeting NOX enzymes in the central nervous system: therapeutic opportunities
Sorce, S., Krause, K., & Jaquet, V. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1014-5 · Cited by 84
“NOX enzymes are increasingly recognized as key regulators of pathological situations where oxidative stress is involved and leads to tissue oxidative damage, such as pulmonary fibrosis, diabetic nephropathy, and vascular and CNS pathologies [81].”
BackgroundSelf-citationSun, Q.-A., Hess, D. T., Wang, B., Miyagi, M., & Stamler, J. S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.046 · Cited by 76
Godfrey, R., Arora, D., Bauer, R., Stopp, S., Müller, J. P., Heinrich, T., Böhmer, S., Dagnell, M., Schnetzke, U., Scholl, S., et al. (2012) · Blood · doi:10.1182/blood-2011-02-336446 · Cited by 93
Voltage-Gated Proton Channels as Novel Drug Targets: From NADPH Oxidase Regulation to Sperm Biology
Seredenina, T. S., Demaurex, N., & Krause, K. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5806 · Cited by 79
“It should be noted that this list is similar to possible indications of inhibitors of the phagocyte NOX (76), and future research will need to determine which of both is the more promising therapeutic avenue.”
Self-citationMittal, M., Gu, X. Q., Pak, O., Pamenter, M. E., Haag, D., Fuchs, D. B., SCHERMULY, R. T., Ghofrani, H. A., Brandes, R. P., Seeger, W., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.004 · Cited by 77
“Their possible role in various cardiovascular diseases such as atherosclerosis, hypertension, myocardial infarction, and ischemia–reperfusion injury has been reported [31,32].”
BackgroundHigh-throughput Assays for Superoxide and Hydrogen Peroxide
Zielonka, J., Cheng, G., Zielonka, M., Ganesh, T., Sun, A., Joseph, J., Michalski, R., O'Brien, W. J., Lambeth, J. D., & Kalyanaraman, B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548693 · Cited by 70
“Hence, there is a need for the development of novel drugs based on new targets (10).”
BackgroundSelf-citationThe neuroprotective effects of apocynin
Simonyi, Á. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e535 · Cited by 80
NADPH oxidase inhibitors: a patent review
Kim, J.-A., Neupane, G. P., Lee, E. S., Jeong, B.-S., Park, B. C., & Thapa, P. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.584870 · Cited by 69
“In the lung, ROS-mediated tissue damage is an important factor in the pathogenesis of pulmonary fibrosis, asthma and chronic obstructive pulmonary diseases [44,45].”
BackgroundKim, J. H., Song, S. Y., Park, S. G., Song, S. U., Xia, Y., & Sung, J.-H. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0561 · Cited by 71
The Role of Redox Mechanisms in Cell Signalling
Hancock, J. T. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9189-1 · Cited by 69
Emerging Evidence for the Importance of Phosphorylation in the Regulation of NADPH Oxidases
Bokoch, G. M., Diebold, B., Kim, J.-S., & Gianni, D. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2590 · Cited by 66
“ROS generated via Nox also contribute to a growing number of diseases, including atherosclerosis, hypertension, arthritis, Alzheimer disease and other neurologic disorders, stroke, respiratory syndromes, cancer, and inflammation (68, 80, 85).”
Mohammadi, S., Dolatshahi, M., & Rahmani, F. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01314-5 · Cited by 71
“DUOX2 mutations in humans are associated with congenital hypothyroidism [119].”
BackgroundWalsh, K. P., Minamide, L. S., Kane, S. J., Shaw, A. E., Brown, D. R., Pulford, B., Zabel, M. D., Lambeth, J. D., Kuhn, T. B., & Bamburg, J. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095995 · Cited by 64
Self-citationThe neuroprotective effects of apocynin
Simonyi, Á., Serfozo, P., Lehmidi, T. M. E., Cui, J., Gu, Z., Lubahn, D. B., Sun, A. Y., & Sun, G. Y. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/535 · Cited by 65
“Both in vitro and in vivo studies have shown that NADPH oxidase-derived ROS are the key regulators of inflammatory response and mediate proinflammatory gene expression in glial cell (30, 31).”
BackgroundBosco, E. E., Kumar, S., Marchioni, F., Biesiada, J., Kordos, M., Szczur, K., Meller, J., Seibel, W. L., Mizrahi, A., Pick, E., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.017 · Cited by 64
“, 2008; Bedard and Krause, 2007); whereas apocyanin is thought to nonspecifically inhibit NOX through an indirect mechanism only at high dose (Lambeth et al., 2008; Lapperre et al., 1999;O’Donnell et al., 2003).”
BackgroundInfluentialGianni, D., DerMardirossian, C. M., & Bokoch, G. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.05.007 · Cited by 75
Deng, J., Wang, X., Qian, F., Vogel, S., Xiao, L., Ranjan, R., Park, H., Karpurapu, M., Ye, R. D., Park, G. Y., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101323 · Cited by 59
“There are many reports that indicate that ROS have an important role in the generation of proinflammatory mediators that result in tissue damage and organ dysfunction (1, 22).”
BackgroundThe effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats
Reel, B., Güzeloğlu, M., Bağrıyanık, A., Atmaca, S., Aykut, K., Albayrak, G., & Hazan, E. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.08.020 · Cited by 61
McCann, S., & Roulston, C. L. (2013) · Brain Sciences · doi:10.3390/brainsci3020561 · Cited by 71
“The concentration of superoxide within the phagosome of these cells is very high, however ROS generation may also occur in the extracellular space under a variety of conditions, subjecting surrounding tissues to high ROS levels and resulting in cellular damage [78].”
BackgroundInfluentialNon-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
Gu, Y.-Y., Lu, F., Huang, X., Zhang, L., Mao, W., Yu, X., Liu, X., & Lan, H.-Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.583528 · Cited by 57
Translating the oxidative stress hypothesis into the clinic: NOX versus NOS
Armitage, M. E., Wingler, K., Schmidt, H. H. H. W., & La, M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0544-2 · Cited by 64
“For more details on NADPH oxidase inhibitors and their limitations, we refer to other published reviews [32, 46–48].”
Dual oxidases and hydrogen peroxide in a complex dialogue between host mucosae and bacteria
Allaoui, A., Botteaux, A., Dumont, J. E., Hoste, C., & Deken, X. D. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.10.003 · Cited by 59
Peptide-based inhibitors of the phagocyte NADPH oxidase
Benna, J. E., Dang, P. M., & Périanin, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.020 · Cited by 61
Moribe, H., Konakawa, R., Koga, D., Ushiki, T., Nakamura, K., & Mekada, E. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002957 · Cited by 64
“Our data clearly shows that tetraspanin is a new component for directing DUOX activity, contributing to greater understanding of the molecular mechanisms of ROS generation and disorders caused by impairment of ROS generation systems [58,59].”
BackgroundHou, L., Zhang, C., Wang, K., Liu, X., Wang, H., Che, Y., Sun, F., Zhou, X., Zhao, X., & Wang, Q. (2017) · Toxicology · doi:10.1016/j.tox.2017.02.009 · Cited by 63
“…NADPH oxidase produces neurotoxic extracellular and 5 intracellular reactive oxygen species (ROS) (Lambeth 2004), which amplifies the neuroinflammatory response, resulting in additional neuronal damage (Block et al. 2007; Lambeth et al. 2008; Sorce and Krause 2009; Surace and Block 2012).”
Backgroundvon Löhneysen, K., Noack, D., Hayes, P., Friedman, J. S., & Knaus, U. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.332494 · Cited by 53
“Currently available compounds are either not selective, for example GKT 136901, or of limited bioavailability in vivo (Nox2ds-Tat) or possess considerable unspecific toxicity when tested in cell culture (Nox4ds-Tat) (24).”
BackgroundGeneration of reactive oxygen species in adipose-derived stem cells: friend or foe?
Park, S. G., Kim, J. H., Xia, Y., & Sung, J.-H. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.628315 · Cited by 57
“In addition to the passive production by the mitochondria, intracellular ROS can be directly generated by the NADPH oxidase enzyme (Nox) [11,31,32].”
BackgroundPKCδ activation mediates angiogenesis via NADPH oxidase activity in PC‐3 prostate cancer cells
Kim, J., Koyanagi, T., & Mochly‐Rosen, D. (2010) · The Prostate · doi:10.1002/pros.21310 · Cited by 55
“Among these, the family of NADPH oxidase and the mitochondria systems have emerged as major sources of ROS production [6,7].”
BackgroundJhou, B.-Y., Song, T., Lee, I., Hu, M., & Yang, N.-C. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03036 · Cited by 53
Skin Redox Balance Maintenance: The Need for an Nrf2-Activator Delivery System
Ben-Yehuda Greenwald, M., Ben-Sasson, S., Bianco-Peled, H., & Kohen, R. (2016) · Cosmetics · doi:10.3390/cosmetics3010001 · Cited by 49
Targeting NADPH Oxidase and Phospholipases A2 in Alzheimer’s Disease
Simonyi, A., He, Y., Sheng, W., Sun, A. Y., Wood, W. G., Weisman, G. A., & Sun, G. Y. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8107-7 · Cited by 49
“and pharmacological agents to regulate this enzyme system [93, 94].”
Nox4 B-loop Creates an Interface between the Transmembrane and Dehydrogenase Domains
Jackson, H. M., Kawahara, T., Nisimoto, Y., Smith, S. M. E., & Lambeth, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.084939 · Cited by 49
Self-citationGorin, Y. C., & Wauquier, F. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0010 · Cited by 49
“There has been recently a considerable effort for the generation and development of agents able to inhibit the Nox enzymes in a homolog-specific manner (Altenhofer et al., 2012; Drummond et al., 2011; Gaggini et al., 2011; Jaquet et al., 2009; Kim et al., 2011; Laleu et al., 2010; Lambeth et al., 2008).”
BackgroundNADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents
Babalola, O., Mamalis, A., Lev-Tov, H., & Jagdeo, J. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-013-1416-8 · Cited by 47
“Furthermore, fibroblasts isolated from the lungs of patients with IPF generated increased H2O2 in response to TGF-beta1 and induced death of the respiratory epithelial cells [59, 102].”
InfluentialRole of redoximiRs in fibrogenesis
Fierro‐Fernández, M., Miguel, V., & Lamas, S. (2015) · Redox Biology · doi:10.1016/j.redox.2015.11.006 · Cited by 52
“Oxidative stress is thought to play a significant role in cellular functions involved in skin fibrosis [110].”
BackgroundWang, X., Pinto-Duarte, A., Sejnowski, T. J., & Behrens, M. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4907 · Cited by 46
“Nox2 is inactive in resting cells, but becomes activated to generate superoxide upon assembly of the core complex with the cytoplasmic components, which occurs upon phosphorylation of p47 (125).”
Periarticular Bone Loss in Antigen‐Induced Arthritis
Engdahl, C., Lindholm, C., Stubelius, A., Ohlsson, C., Carlsten, H., & Lagerquist, M. K. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38114 · Cited by 48
“ROS have a primarily proinflammatory role in RA and mediate tissue damage, but low levels of ROS have been shown to have a regulatory function in arthritis (21,25).”
BackgroundNOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction
Taylor, D. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00040 · Cited by 51
“Reflective of the significant interest in NADPH oxidases and disease pathology, aggressive investigation for new and selective small molecular weight inhibitors of NOX subunits is ongoing (reviewed in Lambeth et al., 2008; Jaquet et al., 2009; Cifuentes-Pagano et al., 2012).”
Background
Metadata
- Authors
- Lambeth, J. D., Krause, K.-H., & Clark, R. A.
- Affiliations
- Emory University (US)
- University of Geneva (CH)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Lambeth, J. David
- ORCID
- Clark, Robert A.
- Venue
- Seminars in Immunopathology
- Published
- 2008-05-29
- Volume
- 30
- Issue
- 3
- Pages
- 339-363
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- OpenAlex
- W2031193867
- Cited by
- 212
- References
- 307
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 7 · 2017: 14 · 2016: 11 · 2015: 11 · 2014: 21 · 2013: 16 · 2012: 28
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Seminars in Immunopathology (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (CA084138, R01CA084138, CA 105116)
- National Institute of Allergy and Infectious Diseases (R01AI020866)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- NADPH oxidase, reactive oxygen species, superoxide, hydrogen peroxide, NOX inhibitors, drug development, isoform specificity, oxidative stress, inflammation, aging, hypertension, ischemia-reperfusion injury, neurodegenerative diseases, pulmonary fibrosis, diabetic nephropathy, renal cell carcinoma, host defense, thyroid hormone synthesis
- MeSH terms
- Animals, Drug Evaluation, Enzyme Inhibitors, Humans, Reactive Oxygen Species, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.